Category: NxStage Medical Inc.
NxStage Medical beats expectations with its 4th-quarter and 2013 results, but investors send shares down anyway.
NxStage Medical (NSDQ:NXTM) shares rose today after the medical device company said it just beat estimates with its results for the 4th quarter and last year.
NxStage Medical campaigns to increase awareness of home hemodialysis with the NxStage System One.
NxStage Medical (NSDQ:NXTM) launched a new patient outreach program called NxStage Plus One, through which it hopes to increase awareness of home hemodialysis with the NxStage System One.
NxStage Medical's shares are up today after the medical device company beats its own and Wall Street's expectations with its preliminary 4th-quarter sales numbers.
NxStage Medical (NSDQ:NXTM) saw its stock price climb this morning after reporting preliminary 4th-quarter sales numbers that topped its own forecast and handily beat expectations on Wall Street.
Fresenius renews its pact for the purchase of NxStage Medical's System One hemodialysis device.
Fresenius (NYSE:FMS) and NxStage Medical (NSDQ:NXTM) said they extended a supply deal for NxStage's System One hemodialysis device until 2016.
NxStage Medical and Gambro Renal settle a lawsuit and renew their dialysis tubing supply deal.
NxStage Medical shares are up today on news that the Centers for Medicare & Medicaid Services raised the training payment for home hemodialysis and scrapped its proposal to cut the reimbursement rate for dialysis.
NxStage Medical (NSDQ:NXTM) shares are on the rise this morning after the Centers for Medicare & Medicaid Services announced Friday that it will boost the training rate for home hemodialysis.
NXTM shares were trading at $9.98 apiece as of about 10 a.m. today, up 3.5%.
NxStage touts its System One S, Nx2me Connected Health and Dosing Calculator at the American Society of Nephrology's Annual Kidney Week 2013.
NxStage Medical (NSDQ:NXTM) debuted 3 new products this week during the American Society of Nephrology's Annual Kidney Week 2013.
The Lawrence, Mass-based medical device company trotted out its System One S, the next generation of NxStage's System One. It features higher dialysate flow rates, allowing for a wider range of flexible therapy options.